Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362. - Lowe MA; Cardenas A; Valentin JP; Zhu Z; Abendroth J; Castro JL; Class R; Delaunois A; Fleurance R; Gerets H; Gryshkova V; King L; et al. (Journal of medicinal chemistry, 2022)